Sensei Biotherapeutics (NASDAQ:SNSE – Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.27) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.27), Zacks reports.
Sensei Biotherapeutics Price Performance
Shares of NASDAQ:SNSE opened at $0.51 on Friday. The stock has a market cap of $12.78 million, a price-to-earnings ratio of -0.43 and a beta of 0.16. Sensei Biotherapeutics has a 12 month low of $0.38 and a 12 month high of $1.94. The stock’s 50 day moving average price is $0.47 and its 200 day moving average price is $0.49.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $4.00 price target on shares of Sensei Biotherapeutics in a report on Friday. Oppenheimer lifted their target price on Sensei Biotherapeutics from $3.50 to $4.00 and gave the company an “outperform” rating in a research note on Friday.
Sensei Biotherapeutics Company Profile
Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.
Featured Stories
- Five stocks we like better than Sensei Biotherapeutics
- Stock Sentiment Analysis: How it Works
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- How to Calculate Stock Profit
- MarketBeat Week in Review – 03/24 – 03/28
- How to Profit From Value Investing
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Sensei Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensei Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
